abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Cash Flow (Statement)
-$3.54M
TTM · Period ending: · USD
HQL Operating Cash Flow (Statement)
Latest reported-$3.54Mperiod ending
Latest reported-$3.54Mperiod ending
HQL Cash from Operations (-$1.50M → -$3.54M)
Annual operating cash flow (statement)
High-resolution chart · PNG
HQL operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -2,320,285 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -52,565 | |
| 9,472 | |
| 21,105,099 | |
| 118,300,000 | |
| 1,900,000 | |
| 13,000,000 | |
| 11,800,000 | |
| -3,700,000 | |
| -2,100,000 | |
| -3,200,000 | |
| -3,200,000 | |
| -2,400,000 | |
| -2,600,000 | |
| -1,900,000 | |
| -1,700,000 | |
| -1,500,000 | |
| -1,500,000 |